1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with paclitaxel in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ausema, B; Kamps, W; Kok, JW; Kolk, D; Nijhof, W; Sietsma, H; Veldman, RJ; Vellenga, E | 1 |
| Mayer, LD; Shabbits, JA | 1 |
| Dijkhuis, AJ; Jacobs, S; Kamps, W; Klappe, K; Kok, JW; Kroesen, BJ; Sietsma, H | 1 |
| Fujisawa, T; Hayakawa, T; Ishii, K; Ishitsuka, R; Ito, K; Kobayashi, T; Makino, A; Matsuo, H; Murate, M; Suzuki, M; Suzuki, Y | 1 |
| Aoki, D; Isonishi, S; Iwamori, M; Kiguchi, K; Mikami, M; Takada, H; Tanaka, K | 1 |
| Aoyama, Y; Ichihara, M; Inoue, C; Kawamoto, Y; Kyogashima, M; Mizutani, N; Murate, T; Nishizawa, Y; Nozawa, Y; Sobue, S; Suzuki, M | 1 |
6 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and paclitaxel
| Article | Year |
|---|---|
1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine.
Topics: Animals; Antineoplastic Agents; Cell Survival; Ceramides; Cyclosporins; Drug Synergism; Enzyme Inhibitors; Etoposide; Glucosyltransferases; Morpholines; Neuroblastoma; Paclitaxel; Tumor Cells, Cultured; Vincristine | 2000 |
P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Survival; Ceramides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Glucosyltransferases; Humans; Microscopy, Fluorescence; Morpholines; Paclitaxel; Palmitic Acid; Protein Transport; Tubulin; Tumor Cells, Cultured; Vincristine | 2002 |
PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Ceramides; Cyclin-Dependent Kinase 2; Down-Regulation; Drug Resistance, Neoplasm; Fatty Acids, Monounsaturated; Lipid Metabolism; Mice; Morpholines; Neuroblastoma; Paclitaxel; Polyploidy; Sphingolipids | 2006 |
D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
Topics: 1-Deoxynojirimycin; 4-Chloro-7-nitrobenzofurazan; Cells, Cultured; Ceramides; Cholesterol; Endosomes; Enzyme Activation; Fibroblasts; Glucosyltransferases; Homeostasis; Humans; Lipase; Lysophospholipids; Membrane Microdomains; Monoglycerides; Morpholines; Neuroblastoma; Paclitaxel; Stereoisomerism; Sterol Esterase | 2006 |
Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cell Survival; Cholesterol; Cisplatin; Drug Resistance, Neoplasm; Female; Glycolipids; Glycosyltransferases; Humans; Inhibitory Concentration 50; Morpholines; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Phospholipids; Sialyltransferases | 2012 |
Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation, Neoplastic; Glucosyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; K562 Cells; Male; Meperidine; Morpholines; Paclitaxel; Phosphotransferases (Alcohol Group Acceptor); Prostate; Proteasome Endopeptidase Complex; Proteasome Inhibitors; RNA, Small Interfering; Sp1 Transcription Factor; Sphingolipids; Sphingomyelin Phosphodiesterase | 2017 |